☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
EnteroBiotix
EnteroBiotix Concludes Recruitment for P-II Trial of EBX-102-02 in IBS
November 18, 2024
EnteroBiotix Commences the P-II Clinical Evaluation of EBX-102-02 for the Treatment of Irritable Bowel Syndrome (IBS)
April 3, 2024
Load more...
Back to Home
Modal title
×
Modal body text goes here.